|
ARANZ MEDICAL SilhouetteMobile RECEIVES CE MARK
Christchurch, New Zealand, December 13, 2007 |
|
ARANZ Medical Limited, a leading innovator in wound assessment technology, announces that its ARANZ Medical SilhouetteTM product family is now CE-Marking. With this approval ARANZ Medical is now able to market Silhouette, an efficient solution for collection of wound data at the point-of-care, within the European Union.
The ARANZ Medical Silhouette product family marks a significant advance in the management of patients with skin wounds. With the ageing population and increasing prevalence of diabetes the incidence of wounds is increasing. As opposed to the largely ad hoc methods that have been used to track wound healing progress to date, Silhouette provides a very efficient, integrated, non-contact, and repeatable solution for collecting the information about the wound.
“The Silhouette suite of products is an innovative concept that is improving wound care practice,” says Dr Mark Nixon, Chief Medical Officer at ARANZ Medical Limited. “Over the last 3 years we realized that a better solution could be developed that could be more accurate, more efficient, and more integrated than the currently employed methods. Working closely with wound care professionals we have developed the Silhouette product suite which has received enthusiastic reviews from wound care professionals on several continents.”
“We have been using Silhouette in our wound care facility for collection of assessment data for clinical research” reports Professor Marco Romanelli MD PhD, Director of the Wound Healing unit at the Azienda Ospedaliera Pisana (University of Pisa) and current president of EWMA (European Wound Management Association). “We have found the system to be an efficient method for collecting wound assessment data in a repeatable and organized manner. The product is very usable in any setting where wounds are assessed including research facilities or clinics.”
“Being able to apply the CE Mark to the Silhouette is another notable milestone for ARANZ Medical”, reports Bruce Davey PhD, CEO of ARANZ Medical. “With Silhouette’s significant advantages for all participants in the wound care process including patients, nurses, physicians, wound care centers, home health agencies, insurers, reimbursement agencies, and researchers, we believe that Silhouette will find wide appeal with wound care professionals. We are delighted that Silhouette is now available to assist European researchers and health care professionals provide superior care for their patients.”
The ARANZ Medical Silhouette is available for sale in selected European countries. Additional information can be found on the ARANZ Medical Web Site, www.aranzmedical.com.
ARANZ Medical Limited is a member of the ARANZ Group of companies (www.aranz.com) focused on the development of the Silhouette™ suite of products for wound imaging, measurement and documentation. Silhouette resulted from listening to and working with customers, recognising that a simple technology-based solution could be created that would allow more efficient wound assessment with superior outcomes. For additional information, visit our website at www.aranzmedical.com.
The ARANZ Group of companies (www.aranz.com) has the vision of developing technology based solutions to solve customers’ problems in differing application areas. To date the group has demonstrated technical and commercial success in application areas as diverse as 3D modeling (see www.farfieldtechnology.com), laser surface scanners (see www.fastscan3d.com), data collection for movie making special effects, custom orthotics and prosthetics (see www.hanger.com), and geological data interpretation (see www.leapfrog3d.com).
All trademarks appearing in this release are the property of ARANZ Medical.
Contact:
Bruce Davey
VP, Marketing and Sales
ARANZ Medical Limited
Ground Floor, St Elmo Courts
47 Hereford St
PO Box 3894
Christchurch
New Zealand
Phone: +64 3 374 6120
email: b.davey@aranz.com
|
